within Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01A_AntiinflammatoryAndAntirheumaticProductsNonStero.M01AE15_Flunoxaprofen;

model Flunoxaprofen
  extends Pharmacolibrary.Drugs.ATC.M.M01AE15
  // parameters inherited from base class, duplicate, uncomment and change if necesarry
  /*
  
    weight         = 70,
    F              = 0.9,
    Cl             = 1.6666666666666665e-07,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,
    adminCount     = 1,
    Vd             = 0.01,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600  
  */
  ;

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Flunoxaprofen</td></tr><tr><td>ATC code:</td><td>M01AE15</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>100</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>10</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.6</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Flunoxaprofen is a non-steroidal anti-inflammatory drug (NSAID) of the arylpropionic acid class. It was investigated for treatment of inflammation, pain, and rheumatic conditions. Flunoxaprofen is not currently approved or marketed for clinical use.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic studies are available for flunoxaprofen in humans. The following parameters are estimated based on similarity to other oxaprozin-related NSAIDs (e.g., flurbiprofen, ibuprofen) and standard PK assumptions for this class.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Flunoxaprofen;
